The Cutaneous Spectrum of Lupus Erythematosus
- 27 July 2017
- journal article
- review article
- Published by Springer Nature in Clinical Reviews in Allergy & Immunology
- Vol. 53 (3) , 291-305
Abstract
Systemic lupus erythematosus is a complex autoimmune disease with a wide spectrum of clinical and immunopathological features. Cutaneous and articular manifestations are the most common signs in patients with systemic lupus erythematosus. We here review the pathogenesis and the new classification of cutaneous lupus erythemathosus with a discussion of the significance of the various cutaneous signs. The lesions are classified according to the level of the cellular infiltrate and tissue damage in the epidermis, dermis, and/or subcutis. Furthermore, cutaneous lesions pointing to the presence of a thrombotic vasculopathy and those due to a distinct inflammatory, neutrophilic-mediated reaction pattern are highlighted. Particular attention will be given in describing the histology of skin manifestation. Treatment options for cutaneous lupus erythemathosus have increased with the introduction of new biological therapies. However, the majority of the patients still benefit from antimalarials, which remain the cornerstone of treatment. The evaluation and management of cutaneous lupus erythemathosus patients depend on the clinical findings and associated symptoms.Keywords
This publication has 95 references indexed in Scilit:
- Immunosenescence, Aging, and Systemic Lupus ErythematousAutoimmune Diseases, 2013
- Taming lupus—a new understanding of pathogenesis is leading to clinical advancesNature Medicine, 2012
- Cytokine disturbances in systemic lupus erythematosusArthritis Research & Therapy, 2011
- Genetic susceptibility to systemic lupus erythematosus in the genomic eraNature Reviews Rheumatology, 2010
- Hydroxychloroquine treatment in a community‐based cohort of patients with systemic lupus erythematosusArthritis Care & Research, 2010
- Relationship between blood hydroxychloroquine and desethylchloroquine concentrations and cigarette smoking in treated patients with connective tissue diseasesAnnals of the Rheumatic Diseases, 2007
- Effect of hydroxychloroquine on the survival of patients with systemic lupus erythematosus: data from LUMINA, a multiethnic US cohort (LUMINA L)Annals of the Rheumatic Diseases, 2007
- High serum IFN-α activity is a heritable risk factor for systemic lupus erythematosusGenes & Immunity, 2007
- The new cutaneous mucinoses: A review with an up-to-date classification of cutaneous mucinosesJournal of the American Academy of Dermatology, 1991
- Distinctive cutaneous subsets in the spectrum of lupus erythematosusJournal of the American Academy of Dermatology, 1981